Clinical Trial Update: A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of Lutetium-177-FAP-75 for advanced solid tumors is listed, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Lutetium-177-FAP-75 (Lutetium-177 labeled FAP-75 radiopharmaceutical)

Snippet

Sponsor: Fudan University | Conditions: Solid Tumors | Phase 1 | Status: NOT_YET_RECRUITING